Activating this pathway helps neurons survive, strengthens synaptic connections, and makes neurons more resistant to injury
These numbers should be interpreted cautiously given the different trial designs, but the trend is consistent across multiple analyses
Keep in mind that these are long-term treatments, and it takes time for the medication to build up in your body
RS and ZS collected the data
The GLP-1 Effect: Market Penetration In the UK, 4.2 million adultsnearly 1 in 10had recently used a GLP-1 medication or expressed interest in doing so as of early 2025 Two in five overweight Britons (38%) express interest in using GLP-1s for weight loss when informed about the drugs Across Europe, the GLP-1 market is valued at 9.62 billion in 2025, with robust growth expected due to rising obesity and diabetes rates, improved access, and strong healthcare infrastructure in markets like Germany, France, and the UK Social acceptance is rising, and insurance coverage is likely to expand, further accelerating adoption
For this study, porcine ear skin was used